By uncovering the complexities of the human genome, we drive innovation that advances the fight against cancer and other diseases.
At CruxBio, we believe that true innovation comes from collaboration and teamwork. We bring together leading biotech, healthcare, and technology experts to create a dynamic and multidisciplinary community focused on tackling the most complex challenges in cancer biology.
Our primary focus is on leveraging cutting-edge technologies, including machine learning, cloud engineering, multi-omics, and real-world evidence data analytics, to advance our understanding of genomics and cancer biology. By combining these tools with our deep expertise, we uncover patterns and insights that were previously hidden, unseen and unused.
Our projects leveraged advanced data analysis, machine learning, and cloud computing to extract valuable insights from large-scale genomic and multimodal datasets, driving progress in understanding the complexities of biological systems.
We were a key contributor to Poland's largest genomics initiative, the Thousand Polish Genomes Project, which generated a detailed database of genetic variants specific to the Polish population by sequencing the genomes of over a thousand individuals.
Our Team participated in a global genetic partnership aimed at identifying the genetic factors influencing COVID-19 susceptibility, severity, and outcomes, significantly advancing our understanding of the genetics behind SARS-CoV-2.